The central government's decision to continue controlling supply of the swine flu drug, oseltamivir, will help the drug innovator, Swiss multinational Hoffmann-La Roche, and its Indian licencee,......
GlaxoSmithKline PharmaceuticalsIndia, which on Tuesday posted an 18 per cent growth in net profit for the first quarter of 2009, plans to launch two new drugs and acquire established domestic drug......
Daiichi Sankyo's acquisition of Ranbaxy Laboratories, India's biggest drug maker, may spur hostile takeovers and mergers in India's Rs 50,000 crore pharmaceutical industry, experts and industry......